11/16/2009

Applied Physiology Pty Ltd

Strategic Partnerships Sought for Innovative New Cardiovascular Management Technology

Navigator™ is a new cardiovascular care system for circulatory management of critically ill patients. The care of such patients is complex, expensive and often very difficult. While there is no shortage of measurement in intensive and critical care, there is an astonishing lack of clinical decision support to assist clinicians.

The Navigator technology from Sydney and London based Applied Physiology Pty Ltd, addresses the problem of clinician cognitive overload by simplifying the cardiovascular care of critical patients.

Raw data is acquired from conventional monitoring devices. These data are then used to calculate volume, resistance and cardiac output – key parameters that help clinicians to understand and manage cardiovascular performance. The interpreted data is then presented graphically on a bedside touch screen. The graph shows the patient’s status relative to clinician defined targets. In this way the care team is able to closely monitor and plan the effect of interventions.

The technology is useful in any situation in which resuscitation, stabilization and optimization of hemodynamic and oxygen metabolism is required, including ICU, OR and emergency medicine.

With safety and effectiveness established in a 2008 multi-centre randomised controlled trial, Navigator is poised for market launch in 2010.

As Applied Physiology prepares for market launch in 2010, opportunities exist for OEM companies with suitable monitor technology for integration. Applied Physiology will exhibit at the annual MEDICA conference in Düsseldorf 18-21 November, 2009. To see Navigator or meet with company executives, visit the Australian Pavilion, Hall 17 Stand B58 or see: www.applied-physiology.com

This device is not available for sale or distribution. Regulatory applications have been lodged.